WHY IT MATTERS: If state health authorities move forward with potency restrictions or new labeling requirements, patients who rely on higher-concentration products for legitimate medical purposes may face reduced access or need to significantly adjust their dosing strategies. CLINICAL OVERVIEW: Public health officials are raising concerns about the increasing potency of cannabis products available in the legal market, particularly regarding exposure among adolescents and young people. The discussion centers on how THC concentrations in modern products differ substantially from those in cannabis consumed decades ago, and what that means for developing brains.
Proposed Nebraska Medical Marijuana Emergency Rules Spark Concern (THC Limits, Rural Access)
WHY IT MATTERS: If Nebraska finalizes these emergency rules as written, patients with legitimate medical needs may find themselves rationed to doses too low to provide meaningful relief, with no practical path to adjust their treatment for 90 days at a time. CLINICAL OVERVIEW: Nebraska’s proposed emergency medical cannabis rules include a 5-gram THC dispensing limit every 90 days and a 40-milligram per-dose cap, both of which reflect a fundamental misunderstanding of how cannabis medicine works in clinical contexts. These restrictions could leave patients with serious conditions severely undertreated, particularly those managing chronic pain, cancer-related symptoms, or neurological disorders who often require individualized dosing that far exceeds arbitrary bureaucratic thresholds.
Researcher: Remediated cannabis may still have harmful mold – MJBizDaily
WHY IT MATTERS: If you are using cannabis purchased from a dispensary, you should know that passing a state lab test does not guarantee your product is free from all harmful mold species, which is especially important if you have a weakened immune system or chronic lung conditions. CLINICAL OVERVIEW: Recent research highlights that cannabis products which have undergone remediation processes to address mold contamination may still harbor harmful fungal organisms that current state-mandated testing protocols fail to detect. This raises significant clinical concerns because immunocompromised patients and those with respiratory conditions may be unknowingly exposed to mycotoxins and viable mold spores, and the assumption that vaporization eliminates these contaminants appears to be unsupported by the evidence.